Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2005
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660843A Matrine and salt of organic acid of oxidized matrine and its prepn. process
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660832A Method for extracting and separating general flavone and saponin astragalus root from astragalus root
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660779A Mono- and disubstituted 3-propyl gamma-aminobutyric acids
08/31/2005CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment
08/31/2005CN1660407A Liquid preparation containing penta peptide of thymus and preparing method
08/31/2005CN1660401A Preparation of vital qi drop pills of ageratum and preparing method
08/31/2005CN1660399A Medication for treating arthralgia due to wind-cold dampness and weary muscles and bones
08/31/2005CN1660381A Film coating agent fro treating wound, bone ache caused from wind dampness and preparing method
08/31/2005CN1660377A Medication in use for treating inflammation
08/31/2005CN1660356A Combination of Tibet medicine of containing salt and possessing medicinal effect health care, and preparation metohd
08/31/2005CN1660355A Chinese materia medica preparation for treating wound, rheumatic bone ache and preparing method
08/31/2005CN1660351A Combination of medication of containing astragalus root and dragon's blood resin and application
08/31/2005CN1660349A Combination of medication by using beartyberry and dragon's blood resin as combination of activities
08/31/2005CN1660347A Yinhuang combination, oral taking preparation and injection preparation, preparing method and application
08/31/2005CN1660335A Dripping heart pill preparation for alleviating pains of heart and stomach
08/31/2005CN1660331A Medication for treating wind dampness, rheumatoid disease and preparation method
08/31/2005CN1660322A 'Yinchai' drop pills for treating cold, fever and cough and preparation method
08/31/2005CN1660265A Gel preparation of dual goldthread root and preparing method
08/31/2005CN1660258A 'Longxuejie' soft capsule and preparation method
08/31/2005CN1660229A Soft capsule for treating rheumatoid desease
08/31/2005CN1660209A Film coating agent for treating mastitis of milch cows and preparation methde
08/31/2005CN1660204A Ground substance of plaster of Chinese traditional medicine and plaster for external application prepared from the substance
08/31/2005CN1660193A Tielizhai tablet of keeping in mouth
08/31/2005CN1660191A Oral preparation of Chinese traditional medicine for treating vascular headache and hemicrania, and preparation method
08/31/2005CN1660190A 'Qili' capsule for treating wound and preparation method
08/31/2005CN1660185A Preparation of soft capsule of Chinese traditional medicine for treating rheumatism and preparation method
08/31/2005CN1660184A Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application
08/31/2005CN1660167A Effective part of astragalus, preparing method and application in pharmacy
08/31/2005CN1660161A Combination of Chinese traditional medicine for treating rheumatism, and preparation method and application
08/31/2005CN1660156A Treatment liquid of penetrating skin of Chinese traditional medicine for curing rheumatalgia and preparing method
08/31/2005CN1660152A Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone
08/31/2005CN1660147A Soft capsule of malus asiatica and preparation method
08/31/2005CN1660082A Microcapsule in multilayer film in use for antifan and preparation method
08/31/2005CN1660078A Oral disintegration tablet of bergenin and compound bergenin and preparation method
08/31/2005CN1660051A Method for preparing bath powder of Tibet medicine and its quality control method
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1216983C Medicinal wine compsn and its prepn. method
08/31/2005CN1216913C Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line
08/31/2005CN1216900C Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/31/2005CN1216855C Crystal polymorphism of aminoethylphenoxyacetic acid derivatives
08/31/2005CN1216637C Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
08/31/2005CN1216634C Medicinal composition for treating pain
08/31/2005CN1216624C Antalgic medicine liquor
08/31/2005CN1216615C Plaster for treating rheumatic diseases and psoatic strain and its prepn process
08/31/2005CN1216610C Rheumatism treating medicine
08/31/2005CN1216606C Stable aspirin ointment preparations
08/31/2005CN1216598C 药物用途 Drug use
08/30/2005US6936718 Reacting with acid mixed with solvent; salt formation
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936632 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
08/30/2005US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing
08/30/2005US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof.
08/30/2005US6936616 Pyrimidine matrix metalloproteinase inhibitors
08/30/2005US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936603 Treating autoimmune diseases mediated by cathepsin S
08/30/2005US6936601 Psychological disorders; synergistic mixture
08/30/2005US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005CA2336968C Quinoline derivatives
08/30/2005CA2136331C New pharmaceutical uses of krill enzymes
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/25/2005WO2005078087A1 Antibody targeting osteoclast-associated protein
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077391A1 New synbiotic use
08/25/2005WO2005077380A1 External preparation for treating painful skin wound
08/25/2005WO2005077379A1 Remedy for external use for skin and mucosal injuries caused by viral infection
08/25/2005WO2005076695A2 Methods of modulating neurotrophin-mediated activity
08/25/2005WO2005020982A3 Using selective antagonists of persistent sodium current to treat neurological disorders and pain
08/25/2005WO2005010154A3 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
08/25/2005WO2003098385A3 System and method for transparent early detection, warning, and intervention during a medical procedure
08/25/2005US20050187294 With lipoxin analog inhibitors of polyisoprenyl phosphate signaling; treating diseases associated with phospholipase D (PLD) initiated polymorphoneutrophil (PMN) inflammation
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints
08/25/2005US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5)
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187235 Pyrimidine derivatives useful as selective COX-2 inhibitors
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050187212 Pharmaceutical composition for topical delivery of meloxicam
08/25/2005US20050187197 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
08/25/2005US20050187188 Methods for the treatment of a traumatic central nervous system injury
08/25/2005US20050187185 for tautening skin, in particular for reducing the size of wrinkles in the facial region in a long-lasting manner; comprising crosslinked or uncrosslinked hyaluronic acid associated with heparin
08/25/2005US20050187147 Compositions and methods for increasing drug efficiency
08/25/2005US20050186665 Expressed ligand - vascular intercellular signaling molecule
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/25/2005US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression
08/25/2005US20050186288 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
1 ... 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 ... 1272